当前位置:首页 - 行情中心 - 力生制药(002393) - 财务分析 - 现金流量表

力生制药

(002393)

  

流通市值:59.53亿  总市值:61.28亿
流通股本:2.50亿   总股本:2.58亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金673,934,084.11285,497,465.111,270,340,223.861,024,895,108.01
  收到的税费返还15,589.0615,589.064,402,169.245,597,179.24
  收到其他与经营活动有关的现金91,600,684.5925,372,994.1193,592,769.0769,378,568.17
  经营活动现金流入小计765,550,357.76310,886,048.281,368,335,162.171,099,870,855.42
  购买商品、接受劳务支付的现金187,109,163.897,027,390.25441,216,326.16314,011,048.84
  支付给职工以及为职工支付的现金127,605,321.3173,822,258.16279,858,336.58180,200,848.97
  支付的各项税费120,308,589.8236,839,325.91158,510,624.56122,802,644.78
  支付其他与经营活动有关的现金260,696,456.71104,174,685.54400,486,518.46391,060,456.28
  经营活动现金流出小计695,719,531.64311,863,659.861,280,071,805.761,008,074,998.87
  经营活动产生的现金流量净额69,830,826.12-977,611.5888,263,356.4191,795,856.55
二、投资活动产生的现金流量:
  收回投资收到的现金1,934,975,0001,243,674,0001,942,396,660.431,185,654,872.44
  取得投资收益收到的现金13,074,424.346,118,675.8240,430,198.0964,608,012.13
  处置固定资产、无形资产和其他长期资产收回的现金净额37,442.0826,553.28411,679.29120,026.5
  处置子公司及其他营业单位收到的现金净额0---
  收到的其他与投资活动有关的现金50,000,000-16,429,914.835,121,611.06
  投资活动现金流入小计1,998,086,866.421,249,819,229.11,999,668,452.611,285,504,522.13
  购建固定资产、无形资产和其他长期资产支付的现金12,173,916.335,456,430.3753,750,773.7130,743,011.17
  投资支付的现金2,269,975,0001,143,674,0002,205,005,0001,615,004,000
  支付其他与投资活动有关的现金13,281.0912,500-70,243.85
  投资活动现金流出小计2,282,162,197.421,149,142,930.372,258,755,773.711,645,817,255.02
  投资活动产生的现金流量净额-284,075,331100,676,298.73-259,087,321.1-360,312,732.89
三、筹资活动产生的现金流量:
  吸收投资收到的现金61,104,30061,104,300--
  取得借款收到的现金10,000,000-39,750,00039,750,000
  收到其他与筹资活动有关的现金1,052,017.97--0
  筹资活动现金流入小计72,156,317.9761,104,30039,750,00039,750,000
  偿还债务支付的现金39,750,00010,000,00047,192,994.1360,528,777.78
  分配股利、利润或偿付利息支付的现金92,804,490.88704,431.61121,029,338.78112,761,641.93
  支付其他与筹资活动有关的现金91,745,891.7393,290,782.545,704,585.21673,400
  筹资活动现金流出小计224,300,382.61103,995,214.11213,926,918.12173,963,819.71
  筹资活动产生的现金流量净额-152,144,064.64-42,890,914.11-174,176,918.12-134,213,819.71
四、汇率变动对现金及现金等价物的影响-441.85-745.47-
五、现金及现金等价物净增加额-366,389,011.3756,807,773.04-345,000,137.34-402,730,696.05
  加:期初现金及现金等价物余额1,595,165,053.711,595,165,053.711,940,165,191.051,940,165,191.05
  期末现金及现金等价物余额1,228,776,042.341,651,972,826.751,595,165,053.711,537,434,495
补充资料:
  净利润345,337,466.37-185,960,824.83-
  资产减值准备16,435,037.58-15,251,452.39-
  固定资产和投资性房地产折旧33,682,424.91-67,429,651.43-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧33,682,424.91-67,429,651.43-
  无形资产摊销4,085,575.62-10,856,123.58-
  长期待摊费用摊销195,215.94-29,155.84-
  处置固定资产、无形资产和其他长期资产的损失2,244,788.65-45,791.66-
  固定资产报废损失---95,335.55-
  公允价值变动损失197,794.77--2,899,993.92-
  财务费用1,284,520.32-3,134,711.67-
  投资损失-315,674,594.19--100,178,648.73-
  递延所得税---3,771,989.79-
  其中:递延所得税资产减少---2,364,114.91-
    递延所得税负债增加---1,407,874.88-
  存货的减少-2,650,403.49--21,715,981.66-
  经营性应收项目的减少-29,321,854.53--42,561,425.06-
  经营性应付项目的增加11,867,838.06--31,658,389.24-
  其他--5,551,366.68-
  现金的期末余额1,228,776,042.34-1,595,165,053.71-
  减:现金的期初余额1,595,165,053.71-1,940,165,191.05-
  现金及现金等价物的净增加额-366,389,011.37--345,000,137.34-
公告日期2025-08-222025-04-252025-03-212024-10-30
审计意见(境内)标准无保留意见
TOP↑